首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药华泰八宝丹抗癌作用的研究
引用本文:许锦阶,沈健,等.中药华泰八宝丹抗癌作用的研究[J].汕头大学医学院学报,1994(1):25-28.
作者姓名:许锦阶  沈健
作者单位:汕头大学医学院肿瘤病理研究室
摘    要:华泰八宝丹是一种纯中药制剂,用不同剂量对移植性肉瘤S-180Ehrlich腹水癌和恶性淋巴瘤腹水型LI的小鼠进行治疗,按体表面积计算给成人剂量的10倍、5倍和2.5倍,灌胃给药,经重复实验结果:肉瘤S-180抑瘤率三剂量分别为46%、61%、70%;小鼠生命延长率;Ehrlich腹水癌小鼠高剂量为40%,恶性淋巴瘤腹水型LI中、高剂量为35%和51%,对照阳性药物抑瘤率或生命延长率在25%-48%之间,以上数据经统计学处理,有显著意义或非常显著意义。说明本药有一定抑瘤作用,在小鼠可耐受的剂量下,剂量增加抑瘤效果增加。

关 键 词:中药  华泰八宝丹  移植性肿瘤  实验治疗

Research on the Anti-tumor Effects of Traditional Chinese Medicine HuaTai-BaBao-Dan
Xu Jinjie, Shen Jian, Shen Zhongying.Research on the Anti-tumor Effects of Traditional Chinese Medicine HuaTai-BaBao-Dan[J].Journal of Shantou University Medical College,1994(1):25-28.
Authors:Xu Jinjie  Shen Jian  Shen Zhongying
Abstract:HuaTai-BaBo-Dan(HBBD) is a genuine traditional Chinese medicine.Different dosages of HBBD were administered to mice with transplanted sarcoma S-180,Ehrlich ascitic carcinoma and malignant lymphoma of ascitic type L_I, by perfusing their stomaches in a course treatment. The High-medium-low-dose groups were respectively 10, 5 and 2. 5 times the dosage for the adult human being calculated on the basis of body surface. The results of repeated experiments showed:The tumor-inhibiting rates for sarcoma S-180 were 46%, 61%and 70%in three different dose groups. The life-prolonging rate for the mice with Ehrlich ascitic carcinoma was 40% in the high-dose group; while for the mice with malignant lymphoma LI, the rates were 35% and 51% respectively in the medium -dose and high-dose groups. The tumor-inhibiting rate or life-prolonging rate were between 25%and 48%in the positive control group. Statistic process of the above data showed obvious or very remarkable differences. It has indicated that HBBD can to a certain degree inhibit tumor. Within their endurable dosage, the heavier the dosage, the better the effect of tumor-inbibiting.
Keywords:Traditional Chinese medicine  HuaTai-BaBao-Dan  Transplanted tumor  Mouse  Experiment treatment    
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号